Innovation Scorecard

Background

Innovation Health and Wealth (IHW) identified the need to reduce variation and strengthen compliance of the uptake of NICE Technology Appraisals. One aspect of this recommendation was to develop and publish an innovation scorecard to enable benchmarking and increase transparency to patients and the public.

The publication(s) will assist the NHS in the identification of variation and adoption of NICE Technology Appraisals, which, through discussion, can be explained, challenged and acted upon

The scorecard is produced on a quarterly basis by the Health and Social Care Information Centre (HSCIC), supported by a reference group including representation from:

  • NHS providers
  • Specialised Commissioning
  • NICE
  • DH Commercial Medicines Unit
  • Industry
  • Office of Life Science, Business Innovation and Skills
  • Cabinet Office

National Institute for Health and Care Excellence (NICE) Technology Appraisals

Technology appraisals are recommendations on the use of new and existing medicines and treatments within the NHS, such as:

  • medicines
  • medical devices (for example, hearing aids or inhalers)
  • diagnostic techniques (tests used to identify diseases)
  • surgical procedures (such as repairing hernias)
  • health promotion activities (for example, ways of helping people with diabetes manage their condition).

NICE base their recommendations on a review of clinical and economic evidence.

  • Clinical evidence measures how well the medicine or treatment works.
  • Economic evidence measures how well the medicine or treatment works in relation to how much it costs the NHS – does it represent value for money?

Aim of technology appraisals

NICE is asked to look at particular drugs and devices when the availability of the drug or device varies across the country. This may be because of different local prescribing or funding policies, or because there is confusion or uncertainty over its value. NICE advice provides assurance, ends the uncertainty and helps to standardise access to healthcare across the country.

The NHS is legally obliged to fund and resource medicines and treatments recommended by NICE’s technology appraisals.

NICE TAs for medicines and medical technologies.

See the NHS Digital website for latest innovation scorecard data published by the Health and Social Care Information Centre.

For earlier heat maps on a range of medicines and supporting data see the link below.

October 2016 Heat Maps